# Different Dose Esketamine and Dexmedetomidine for Supplemental Analgesia and Longterm Outcomes

> **NCT06087510** · PHASE4 · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 312 (estimated)

## Conditions studied

- Scoliosis Correction
- Postoperative Analgesia
- Esketamine
- Dexmedetomidine
- Chronic Postsurgical Pain

## Interventions

- **DRUG:** Esketamine

## Key facts

- **NCT ID:** NCT06087510
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-24
- **Primary completion:** 2025-12
- **Final completion:** 2026-09
- **Target enrollment:** 312 (ESTIMATED)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087510, "Different Dose Esketamine and Dexmedetomidine for Supplemental Analgesia and Longterm Outcomes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06087510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*